The Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial Damage

American Journal of Kidney Diseases

Volumn 54, Issue 5, 2009, Pages 891-901

  Meijers, Björn K I ^a   Van kerckhoven, Soetkin ^b   Verbeke, Kristin ^a   Dehaen, Wim ^c   Vanrenterghem, Yves ^a   Hoylaerts, Marc F ^b   Evenepoel, Pieter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

4 cresol; cell deprived microparticles; endothelium; hemodialysis; p Cresol; p cresyl sulfate; uremia

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; CRESOL; CRESYL SULFATE; PADGEM PROTEIN; PHOSPHORUS; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PLATELET MICROPARTICLE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; UMBILICAL VEIN;

AGED; BIOLOGICAL MARKERS; CELLS, CULTURED; CHRONIC DISEASE; CRESOLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UREMIA;

EID: 70350031206     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.022     Document Type: Article

References (32)

1. Sarnak M., and Levey A. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35 suppl 1 (2000) S117-S131
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
4. Meijers B.K.I., Bammens B., De Moor B., Verbeke K., Vanrenterghem Y., and Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73 (2008) 1173-1180
5. Schiffrin E.L., Lipman M.L., and Mann J.F.E. Chronic kidney disease: Effects on the cardiovascular system. Circulation 116 (2007) 85-97
6. Deanfield J., Donald A., Ferri C., et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23 (2005) 7-17
7. Dou L., Bertrand E., Cerini C., et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65 (2004) 442-451
8. Faure V., Dou L., Sabatier F., et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 3 (2006) 566-573
9. Cerini C., Dou L., Anfosso F., et al. p-Cresol, an uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 92 (2004) 140-150
10. Boulanger C.M., Scoazec A., Ebrahimian T., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104 (2001) 2649-2652
11. Amabile N., Guerin A.P., Leroyer A., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16 (2005) 3381-3388
12. Abid Hussein M.N., Böing A.N., Sturk A., Hau C.M., and Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 98 (2007) 1096-1107
13. Martinez A.W., Recht N.S., Hostetter T.H., and Meyer T.W. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol 16 (2005) 3430-3436
14. de Loor H., Bammens B., Evenepoel P., De Preter V., and Verbeke K. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem 51 (2005) 1535-1538
15. Gamage N., Barnett A., Hempel N., et al. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90 (2006) 5-22
16. Schepers E., Meert N., Glorieux G., Goeman J., Van der Eycken J., and Vanholder R. p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22 (2007) 592-596
17. Davies S.J., Phillips L., Naish P.F., and Russell G.I. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 17 (2002) 1085-1092
18. Enjeti A., Lincz L., and Seldon M. Detection and measurement of microparticles: An evolving research tool for vascular biology. Semin Thromb Hemost 33 (2007) 771-779
19. Feigenbaum J., and Neuberg C. Simplified method for the preparation of aromatic sulfuric acid esters. J Am Chem Soc 63 (1941) 3529-3530
20. Simak J., and Gelderman M.P. Cell membrane microparticles in blood and blood products: Potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20 (2006) 1-26
21. Bernal-Mizrachi L., Jy W., Jimenez J., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145 (2003) 962-970
22. Simak J., Gelderman M.P., Yu H., Wright V., and Baird A. Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome. J Thromb Haemost 4 (2006) 1296-1302
23. Chirinos J.A., Heresi G.A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45 (2005) 1467-1471
24. Al-Massarani G., Vacher-Coponat H., Paul P., et al. Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. Am J Transplant 8 (2008) 2360-2367
25. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., and Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
26. Teng M., Wolf M., Ofsthun M.N., et al. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16 (2005) 1115-1125
27. Coleman M.L., Sahai E.A., Yeo M., Bosch M., Dewar A., and Olson M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3 (2001) 339-345
28. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95-105
29. Lesaffer G., De Smet R., Belpaire F.M., et al. Urinary excretion of the uraemic toxin p-cresol in the rat: Contribution of glucuronidation to its metabolization. Nephrol Dial Transplant 18 (2003) 1299-1306
30. Depner T., and Himmelfarb J. Uremic retention solutes: The free and the bound. J Am Soc Nephrol 18 (2007) 675-676
31. Meyer T.W., Peattie J.W., Miller J.D., et al. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18 (2007) 868-874
32. Meijers B.K.I., Weber V., Bammens B., et al. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. Artif Organs 32 (2008) 214-219